Literature DB >> 6869015

Pneumococcal meningitis and bacteraemia in Danish children 1969-1978. Serotypes, incidence and outcome.

F K Pedersen, J Henrichsen.   

Abstract

The incidence of pneumococcal meningitis in Danish children during 1969-1978 was estimated to be 2.1/year/100,000 children from 0 to 14 years old. Fifty-five per cent of 146 children with pneumococcal meningitis and 61% of 61 with bacteraemia were below 2 years of age. Mortality from meningitis was 13% and from bacteraemia 7%. Of the children with meningitis, 14% had sequelae at the time of discharge from the hospital. Sequelae were not seen after bacteraemia. Among 277 pneumococcal isolates from spinal fluid and blood from Danish children during 1969-1978, serotypes 14, 18C, 6A + 6B, 23F, 7F and 19F, in that order of frequency, were the most common ones, accounting for 69% of all isolates. Serotypes included in current 14-valent pneumococcal polysaccharide vaccines made of 80% of all types, when types 6A and 6B are considered together (because it has been shown that they offer cross-protection).

Entities:  

Mesh:

Year:  1983        PMID: 6869015     DOI: 10.1111/j.1699-0463.1983.tb00021.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  5 in total

1.  Seroepidemiologic characterization of Streptococcus pneumoniae in a Saudi hospital.

Authors:  S S Hussein; C C Anokute
Journal:  J Natl Med Assoc       Date:  1987-11       Impact factor: 1.798

2.  Pneumococcal infections.

Authors:  M R Lockley; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-21

3.  Outcome of invasive pneumococcal disease: a UK based study. Oxford Pneumococcal Surveillance Group.

Authors:  F Shackley; K Knox; J B Morris; D Crook; D Griffiths; R Mayon-White; R George; L Willocks; E Moxon
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

4.  Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.

Authors:  H F Helwig
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life.

Authors:  Aurélie Allemann; Julia G Kraemer; Insa Korten; Kathryn Ramsey; Carmen Casaulta; Daniel Wüthrich; Alban Ramette; Andrea Endimiani; Philipp Latzin; Markus Hilty
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.